The U.S. Army Medical Materiel Development Activity has selected Irving Burton Associates to develop and perform marketing strategies to assist in the migration of a skin treatment product to a commercial partner.
IBA will work to design brand and message elements, develop marketing products and implement communication strategy to support the Cutaneous Leishmaniasis Topical Cream’s transition, Irving Burton Associates said Thursday.
The U.S. Army Medical Research Acquisition Activity awarded the task order through IBA’s Telemedicine & Advanced Technology Research Center vehicle.